TGFB1 and cancer: We identified six immune subtypes spanning cancer tissue types and molecular subtypes to define immune response patterns having an influence on prognosis, including C1 (wound healing), C2 (INF-γ dominant), C3 (inflammatory), C4 (lymphocyte depleted), C5 (immunologically quiet), and C6 (TGFβ dominant).